STUART BLUME has been professor and chair of the Department of Science and Technology Dynamics, University of Amsterdam, The Netherlands, since 1982. Between 1977 and 1980 he was research secretary of the Committee on Social Inequalities in Health, Department of Health and Social Security, London. Since that time, his research has focused in particular on sociological aspects of medical research and innovation. Principal publications in this area include Insight and Industry: The Dynamics of Technological Change in Medicine (MIT Press, 1992); (with A. Hiddinga) ''Social contexts of technological change in medicine: The origins and transformation of obstetric pelvimetry" in Science, Technology and Human Values (1992); and "Social process and the assessment of a new imaging technique" in the International Journal of Technology Assessment in Health Care (1993). Dr. Blume has been a consultant to the OECD for many years and was recently president of the Research Committee on Sociology of Science of the International Sociological Association.
ENRIQUETA C. BOND is president of the Burroughs Wellcome Fund, a private independent foundation with a mission to advance the medical sciences. Her past employment experiences have included the position of executive director of the Institute of Medicine and faculty positions at Southern Illinois University School of Medicine and at Chatham College. She has a B.A. from Wellesley College in zoology and physiology, an M.A. in genetics from the University of Virginia, and a Ph.D. in molecular biology from Georgetown University.
HOLLY V. DAWKINS is a research assistant in the Divisions of Health Care at the Institute of Medicine. Since joining the Institute of Medicine in June 1988, she has worked on over a dozen IOM projects, in particular the IOM program on technological innovation in medicine and the series Medical Innovation at the Crossroads. In 1991, she received the Institute of Medicine staff award for her work on the Institute of Medicine study to evaluate the artificial heart program of the National Heart, Lung, and Blood Institute. Holly earned her A.B. with honors in English from Brown University in 1986.
STAN N. FINKELSTEIN is senior lecturer in Health Policy and Management at the Massachusetts Institute of Technology (MIT) Sloan School of Management and a consultant for Charles River Associates. He received the S.M. and S.B. degrees from MIT in chemical engineering in 1971 and the M.D. from Harvard Medical School in 1975. Since 1975, he has actively worked in the field of medical technology assessment and transfer at MIT where he has conducted research and taught classes in the areas of the development and evaluation of medical practice and technology and in health policy. Among his interests have been the business-government interface related to the pharmaceutical industry, especially clinical research design and third party reimbursement. Dr. Finkelstein